Fundraising Fox

Dimension Inx

Chicago, US · Founded 2020 · Delaware corporation · 23 employees on LinkedIn · 6 known investors

Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging. The platform combines materials science, 3D printing, and digital manufacturing to create biosynthetic and biohybrid scaffolds for implantable and injectable products across sports medicine, orthopedics, plastic surgery, dental, and cell therapy applications.

Founders & leadership

Dimension Inx was founded in 2020 by Caralynn Nowinski Collens, M.D., Ramille Shah, Ph.D., Ramille Shah, and Caralynn Collens.

CN
Caralynn Nowinski Collens, M.D.Co-founder & CEO
RS
Ramille Shah, Ph.D.Co-founder & CSO
RS
Ramille ShahCo-founder
CC
Caralynn CollensCo-founder

Board

RC
Rima Chakrabartiin𝕏Board directorPartner at KdT Ventures

Investors · 6

Reported raises · per SEC filings

Form D private placements

$17.7M disclosed across 3 rounds · 2020–2023

$12MraisedFeb 2023 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rima ChakrabartiDirector
  • Ramille ShahDirector
  • Caralynn CollensExecutive Officer, Director
Offering amount
$15M
Amount sold
$12M
First sale
Jan 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.3MraisedNov 2021 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Caralynn CollensExecutive Officer, Director
  • Ramille ShahExecutive Officer, Director
  • Adam JakusExecutive Officer, Director
Offering amount
$2.3M
Amount sold
$2.3M
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.4MraisedNov 2020 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Caralynn CollensExecutive Officer, Director
Offering amount
$3.4M
Amount sold
$3.4M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Dimension Inx do?
Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging. The platform combines materials science, 3D printing, and digital manufacturing to create biosynthetic and biohybrid scaffolds for implantable and injectable products across sports medicine, orthopedics, plastic surgery, dental, and cell therapy applications.
Who founded Dimension Inx?
Dimension Inx was founded by Caralynn Nowinski Collens, M.D., Ramille Shah, Ph.D., Ramille Shah, Caralynn Collens in 2020.
Who are Dimension Inx's investors?
Dimension Inx's investors include Better Ventures Central Llc, Lofty Ventures, Pathway Bioventures, Portal Innovations, Solas BioVentures, KdT Ventures.
How much funding has Dimension Inx raised?
Dimension Inx has disclosed $17.7M raised across 3 rounds.
Where is Dimension Inx headquartered?
Dimension Inx is headquartered in Chicago, US.